Literature DB >> 24759852

Family-based treatment of early childhood obsessive-compulsive disorder: the Pediatric Obsessive-Compulsive Disorder Treatment Study for Young Children (POTS Jr)--a randomized clinical trial.

Jennifer Freeman1, Jeffrey Sapyta2, Abbe Garcia1, Scott Compton2, Muniya Khanna3, Chris Flessner1, David FitzGerald2, Christian Mauro2, Rebecca Dingfelder2, Kristen Benito1, Julie Harrison3, John Curry2, Edna Foa3, John March2, Phoebe Moore2, Martin Franklin3.   

Abstract

IMPORTANCE: Cognitive behavior therapy (CBT) has been established as efficacious for obsessive-compulsive disorder (OCD) among older children and adolescents, yet its effect on young children has not been evaluated sufficiently.
OBJECTIVE: To examine the relative efficacy of family-based CBT (FB-CBT) involving exposure plus response prevention vs an FB relaxation treatment (FB-RT) control condition for children 5 to 8 years of age. DESIGN, SETTING, AND PARTICIPANTS: A 14-week randomized clinical trial (Pediatric Obsessive-Compulsive Disorder Treatment Study for Young Children [POTS Jr]) conducted at 3 academic medical centers between 2006 and 2011, involving 127 pediatric outpatients 5 to 8 years of age who received a primary diagnosis of OCD and a Children's Yale-Brown Obsessive Compulsive Scale total score of 16 or higher.
INTERVENTIONS: Participants were randomly assigned to 14 weeks of (1) FB-CBT, including exposure plus response prevention, or (2) FB-RT. MAIN OUTCOMES AND MEASURES: Responder status defined as an independent evaluator-rated Clinical Global Impression-Improvement scale score of 1 (very much improved) or 2 (much improved) and change in independent evaluator-rated continuous Children's Yale-Brown Obsessive Compulsive Scale total score. RESULTS Family-based CBT was superior to FB-RT on both primary outcome measures. The percentages of children who were rated as 1 (very much improved) or 2 (much improved) on the Clinical Global Impression-Improvement scale at 14 weeks were 72% for FB-CBT and 41% for FB-RT. The effect size difference between FB-CBT and FB-RT on the Clinical Global Impression-Improvement scale was 0.31 (95% CI, 0.17-0.45). The number needed to treat (NNT) with FB-CBT vs FB-RT was estimated as 3.2 (95% CI, 2.2-5.8). The effect size difference between FB-CBT and FB-RT on the Children's Yale-Brown Obsessive Compulsive Scale at week 14 was 0.84 (95% CI, 0.62-1.06). CONCLUSIONS AND RELEVANCE: A comprehensive FB-CBT program was superior to a relaxation program with a similar format in reducing OCD symptoms and functional impairment in young children (5-8 years of age) with OCD. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00533806.

Entities:  

Mesh:

Year:  2014        PMID: 24759852      PMCID: PMC4511269          DOI: 10.1001/jamapsychiatry.2014.170

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  39 in total

1.  The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction.

Authors:  Susan E Swedo; Henrietta L Leonard; Judith L Rapoport
Journal:  Pediatrics       Date:  2004-04       Impact factor: 7.124

Review 2.  Treatment of obsessive compulsive disorder.

Authors:  Martin E Franklin; Edna B Foa
Journal:  Annu Rev Clin Psychol       Date:  2011       Impact factor: 18.561

3.  Functional impairment in clinical samples of Norwegian and Swedish children and adolescents with obsessive-compulsive disorder.

Authors:  Robert Valderhaug; Tord Ivarsson
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-05       Impact factor: 4.785

4.  Cognitive-behavioral treatment of childhood obsessive-compulsive disorder in community-based clinical practice: clinical significance and benchmarking against efficacy.

Authors:  Lara J Farrell; Barbara Schlup; Mark J Boschen
Journal:  Behav Res Ther       Date:  2010-02-02

5.  Developmental aspects of obsessive compulsive disorder: findings in children, adolescents, and adults.

Authors:  D A Geller; J Biederman; S Faraone; A Agranat; K Cradock; L Hagermoser; G Kim; J Frazier; B J Coffey
Journal:  J Nerv Ment Dis       Date:  2001-07       Impact factor: 2.254

6.  Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood.

Authors:  S J Perlmutter; S F Leitman; M A Garvey; S Hamburger; E Feldman; H L Leonard; S E Swedo
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

7.  Rationale and principles for early intervention with young children at risk for anxiety disorders.

Authors:  Dina R Hirshfeld-Becker; Joseph Biederman
Journal:  Clin Child Fam Psychol Rev       Date:  2002-09

8.  Efficacy and safety of fluoxetine in preschool children with obsessive-compulsive disorder.

Authors:  Murat Coskun; Salih Zoroglu
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-06       Impact factor: 2.576

9.  Early childhood OCD: preliminary findings from a family-based cognitive-behavioral approach.

Authors:  Jennifer B Freeman; Abbe M Garcia; Lisa Coyne; Chelsea Ale; Amy Przeworski; Michael Himle; Scott Compton; Henrietta L Leonard
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-05       Impact factor: 8.829

10.  Decreased family accommodation associated with improved therapy outcome in pediatric obsessive-compulsive disorder.

Authors:  Lisa J Merlo; Heather D Lehmkuhl; Gary R Geffken; Eric A Storch
Journal:  J Consult Clin Psychol       Date:  2009-04
View more
  38 in total

Review 1.  Family Accommodation of Child and Adolescent Anxiety: Mechanisms, Assessment, and Treatment.

Authors:  Kaila R Norman; Wendy K Silverman; Eli R Lebowitz
Journal:  J Child Adolesc Psychiatr Nurs       Date:  2015-08-04

2.  A META-ANALYSIS OF COGNITIVE BEHAVIOR THERAPY AND MEDICATION FOR CHILD OBSESSIVE-COMPULSIVE DISORDER: MODERATORS OF TREATMENT EFFICACY, RESPONSE, AND REMISSION.

Authors:  Joseph F McGuire; John Piacentini; Adam B Lewin; Erin A Brennan; Tanya K Murphy; Eric A Storch
Journal:  Depress Anxiety       Date:  2015-06-30       Impact factor: 6.505

3.  Targeted Family Intervention for Complex Cases of Pediatric Obsessive-Compulsive Disorder: A Randomized Controlled Trial.

Authors:  Tara S Peris; Michelle S Rozenman; Catherine A Sugar; James T McCracken; John Piacentini
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2017-10-14       Impact factor: 8.829

4.  Children's and Parents' Ability to Tolerate Child Distress: Impact on Cognitive Behavioral Therapy for Pediatric Obsessive Compulsive Disorder.

Authors:  Robert R Selles; Martin Franklin; Jeffrey Sapyta; Scott N Compton; Doug Tommet; Richard N Jones; Abbe Garcia; Jennifer Freeman
Journal:  Child Psychiatry Hum Dev       Date:  2018-04

5.  Examining the Psychometric Properties of the Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire in Two Samples of Youth with OCD.

Authors:  B Wellen; L C Skriner; J Freeman; E Stewart; A Garcia; J Sapyta; M Franklin
Journal:  Child Psychiatry Hum Dev       Date:  2017-02

Review 6.  Depression and Anxiety in Preschoolers: A Review of the Past 7 Years.

Authors:  Diana J Whalen; Chad M Sylvester; Joan L Luby
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2017-03-18

7.  Parent-Based Treatment as Efficacious as Cognitive-Behavioral Therapy for Childhood Anxiety: A Randomized Noninferiority Study of Supportive Parenting for Anxious Childhood Emotions.

Authors:  Eli R Lebowitz; Carla Marin; Alyssa Martino; Yaara Shimshoni; Wendy K Silverman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-03-07       Impact factor: 8.829

8.  Fear extinction learning as a predictor of response to cognitive behavioral therapy for pediatric obsessive compulsive disorder.

Authors:  Daniel A Geller; Joseph F McGuire; Scott P Orr; Brent J Small; Tanya K Murphy; Kathleen Trainor; Rachel Porth; Sabine Wilhelm; Eric A Storch
Journal:  J Anxiety Disord       Date:  2019-03-01

9.  D-Cycloserine augmentation of cognitive behavior therapy for pediatric OCD: Predictors and moderators of outcome.

Authors:  Sabine Wilhelm; Noah Berman; Brent J Small; Rachel Porth; Eric A Storch; Daniel Geller
Journal:  J Affect Disord       Date:  2018-07-20       Impact factor: 4.839

Review 10.  Family accommodation in obsessive-compulsive and anxiety disorders: a five-year update.

Authors:  Eli R Lebowitz; Kaitlyn E Panza; Michael H Bloch
Journal:  Expert Rev Neurother       Date:  2015-12-22       Impact factor: 4.618

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.